Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer

NCT: NCT02433197 · COMPLETED

NCT IDNCT02433197
StatusCOMPLETED
Start Date2015-12

Brief Summary

Background: Patients with testicular germ cell cancer (GCC) have a high cure rate, however impaired muscle function and fatigue are the most common complications among patients with GCC undergoing treatment with chemotherapy. Although exercise is widely recommended, information about physiopathological effects of cancer therapy in skeletal muscle is very limited. Methods/Design: The present study is a randomized controlled trial comparing an individualized program of muscular strength and endurance with aerobic training compared to a control group. All variables will be measured at the beginning and at the end of a 8-week intervention by the same evaluator, who will hide the disposition of participants to each group. Besides, it will be monitoring during de following 6 months (24 weeks) after training for all outcome variables.

Frequently Asked Questions

What is Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer?

Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer is a clinical trial registered under NCT02433197. Current status: COMPLETED.

What is the status of NCT02433197?

The current status of NCT02433197 (Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer) is: COMPLETED.

When did Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer start?

Effectiveness of an Individualized Program of Muscular Strength and Endurance Program for Improving Germ Cell Cancer started on 2015-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.